Covered Outpatient Drug Final Rule with Comment (CMS-2345-FC): Webinar Details
Monday, February 8, 2016
Posted by: Ryan Yamamura
Covered Outpatient Drug Final Rule with Comment (CMS-2345-FC)
CMS will host the following webinars to provide an overview of the Covered Outpatient Drugs final rule with comment that was displayed in the Federal Register on January 21, 2016.
Wednesday, February, 10, 2016, 12:30 – 2:00 p.m. ET: Drug Manufacturers and Government Pricing/Programs
PIN: 644 043 119
This webinar will be geared towards drug manufacturers and those with responsibilities or involvement in government pricing/programs. While we will provide a broad overview of the final rule with comment, the focus of this webinar will be manufacturer reporting requirements and rebate requirements including topics related to Average Manufacturer Price (AMP), best price, 5i drugs, authorized generics, covered outpatient drug definition, innovator multiple source drug and single source drug definitions, drugs approved exclusively for pediatric indications, and line extension drugs.
Thursday, February 11, 2016, 12:30 – 2:00 p.m. ET: Pharmacy Industry
PIN: 995 608 816
This webinar will be geared toward the pharmacy industry including retail community pharmacies and pharmacy trade organizations. While we will provide a broad overview of the final rule with comment, the focus of this webinar will primarily be within the area of pharmacy reimbursement, including the Federal upper limits (FULs), Actual Acquisition Cost, Professional Dispensing Fee, and Reimbursement for Federal Discount Programs (340B and Federal Supply Schedule (FSS)).
Registration is not required for the webinars and space is limited. Please contact RxDRUGPolicy@cms.hhs.gov with questions.
Please visit the Covered Outpatient Drugs Policy page for more details on the final rule with comment.